SAB Biotherapeutics Inc — Dividend History & Yield (NASDAQ:SABS) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notícias

Ações da SAB Biotherapeutics iniciam com recomendação de compra pela UBS

SAB Biotherapeutics stock initiated with Buy rating at UBS on diabetes drug potential

Guggenheim inicia cobertura da SAB Biotherapeutics com recomendação de compra

Guggenheim initiates SAB Biotherapeutics stock with Buy rating on T1D potential

SAB Biotherapeutics reduz tamanho do conselho após renúncia de dois diretores

SAB Biotherapeutics reduces board size following resignations of two directors

Acionistas da SAB Biotherapeutics aprovam alteração no plano de ações e proposta de conversão da Série B

SAB Biotherapeutics shareholders approve equity plan amendment and Series B conversion proposal

Ações da SAB Biotherapeutics mantêm recomendação de compra pela H.C. Wainwright após dados positivos de tratamento para diabetes

SAB Biotherapeutics stock maintains Buy rating at H.C. Wainwright on positive diabetes treatment data

Chardan Capital lowers SAB Biotherapeutics stock price target to $12 from $20

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release